Literature DB >> 15685044

Long term survival with adjuvant carboplatin, paclitaxel, and radiation therapy in anaplastic thyroid cancer.

Robert Haddad1, Anand Mahadevan, Marshall R Posner, Christopher Sullivan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15685044     DOI： 10.1097/01.coc.0000153282.03031.59

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


× No keyword cloud information.
  4 in total

1.  Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy.

Authors:  Marshall Tulloch-Reid; Monica C Skarulis; Steven I Sherman; Nicholas J Sarlis; Libero Santarpia
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

Review 2.  New trends in the treatment of undifferentiated carcinomas of the thyroid.

Authors:  Paolo Miccoli; Gabriele Materazzi; Alessandro Antonelli; Erica Panicucci; Gianluca Frustaci; Piero Berti
Journal:  Langenbecks Arch Surg       Date:  2006-11-28       Impact factor: 2.895

3.  Aggressive multimodal approach for anaplastic thyroid cancer and long-term survival.

Authors:  Nasir Hussain; Usman Mustafa; Su Hyeon Jung; Alan D Gilman
Journal:  Case Rep Oncol Med       Date:  2013-02-27

4.  Paclitaxel loading in PLGA nanospheres affected the in vitro drug cell accumulation and antiproliferative activity.

Authors:  Luisa Vicari; Teresa Musumeci; Ignazio Giannone; Luana Adamo; Concetta Conticello; Ruggero De Maria; Rosario Pignatello; Giovanni Puglisi; Massimo Gulisano
Journal:  BMC Cancer       Date:  2008-07-25       Impact factor: 4.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.